Friday - January 25, 2008
 Dear Subscriber, The markets plunged yesterday following a speech by Fed Chairman Ben Bernanke and a sharp contraction in the regional Philadelphia Fed survey. The latter is closely watched because it is generally considered to provide a "real-time" assessment of economic conditions (as opposed to lagging data). I understand that many of you are nervous about your investments. It is okay to be concerned about the direction of the markets, but you should never let your emotions interfere with your trading decisions. To help you continue to make smart (and unemotional) decisions, I wrote the Investment Ideas column today with a focus on how to find good stocks that are currently "on sale". Next week, we will have fewer financial-related firms reporting, shifting the headlines towards companies that could potentially have good numbers. I am hopeful that this, combined with the forthcoming Fed meeting, will give us the rebound that we all have been waiting for. Wishing you prosperity, 1. ZACKS RANK BUY STOCKS Zacks #1 Rank stocks average a 32% annual return. Every day on Zacks.com we highlight four new Zacks Rank Buy stocks based on the four main schools of investing: Aggressive Growth, Momentum, Growth & Income and Value. Netflix (NFLX) just reported its third straight quarter that exceeded analyst expectations. The stock has a ROE of 13%, much better than the 2% industry average. Read the full analysis on NFLX now! Monsanto Co. (MON) delivered a strong fiscal first quarter in early January. Monsanto upped its full-year earnings per share guidance as did Wall Street. Read the full analysis on MON now! Knight Capital Group, Inc. (NITE) is one of the few beneficiaries of the uncertainty and volatility in the markets. Read the full analysis on NITE now! UniFirst Corp. (UNF) surprised to the upside by 18.42% in the first quarter 2008, reporting record revenues and earnings. Read the full analysis on UNF now!
2. BEST OF EQUITY RESEARCH The Zacks Equity Research team of 50 analysts generates a mountain of timely research every day that is geared towards long term stock investing. Here we turn the spotlight on some of their hottest insights. Some Biotechs are Defensive Plays Stocks featured recently include DuPont Chemical (DD), Valero (VLO), UAL Corp. (UAUA) and Aetna (AET). To see the latest analyst posts, click here. Economic Weakness, But No Recession Gilead Sciences (GILD) - Reasons for Optimism. For the full Zacks research report, click here. Ness Technologies (NSTC) - Missing Estimates. For the full Zacks research report, click here. Fear, Not Forecasts Total Earnings Battle to Stay in the Black
3. STRATEGIES & IDEAS Here you will find fresh articles loaded with profitable investment strategies and ideas to help you beat the market. Today we highlight... Unique Markets Present Unique Opportunities This strategy finds stocks at discount valuations with a positive trend in earnings estimates. Four stocks that pass this screen's test include EK, OLN, RSH and VOL. More... FLIR Systems, Inc. (FLIR) Using Moving Averages How Will We Recover? Most of the strategies highlighted in the articles above were created using the Zacks Research Wizard screening and backtesting software. Learn more about this powerful tool and get your free copy of our special report "Top 10 Stock Screening Strategies". More... 4. ZACKS EXTRA Mitch Zacks, Portfolio Manager at Zacks Investment Management, says the stock market is headed higher and the Fed will cut rates again by month's end. Listen to his audio here. Click here for more Zacks audio.
Aggressive Growth Investing Splits Aggressive Growth Investing Home: Go there now. Other Investing Education Resources
Hutchinson Technology (HTCH) Despite current bearishness, there are plenty of catalysts to push the company higher, including an upcoming earnings report. Read the complete commentary. Options homepage: Go there now.
If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS! http://at.zacks.com/?id=2299 Regards and Happy Investing, Charles Rotblut, CFA p.s. What is the mission for Zacks Profit from the Pros? Click here to find out how we will help you become a more successful investor. The performance of the Zacks Rank portfolios shown above for annual and year-to-date periods are the linked monthly total returns (price changes + dividends) of equal weighted hypothetical portfolios, consisting of those stocks with the indicated Zacks Rank, assuming monthly rebalancing and zero transaction costs. These are not the returns of actual portfolios. The hypothetical portfolios were created at the beginning of each month from Jan 1988 forward based on the values of the Zacks Rank available to Zacks' clients before the beginning of each month. The portfolios created monthly from 1988 through September 2006 exclude ADRS and are comprised of stocks that have the indicated Zacks Rank and were covered by at least two analysts at the time of the stocks inclusion in the portfolio. Starting in October 2006 and going forward, the portfolios are comprised of all stocks with the indicated Zacks Rank and do not exclude ADRs, which is more reflective of the list of stocks that customers will find on the Zacks web sites. 2007 returns are for the period of Jan 1 - Jun 30, 2007. These performance numbers have been audited from 1995 through 2003 by Autschuler Melovan, a division of American Express Financial. The S&P 500 Index is a well-known, unmanaged index of the prices of 500 large-company common stocks, mainly blue-chip stocks, selected by Standard & Poor's. The S&P 500 Index assumes reinvestment of dividends but does not reflect advisory fees. An investor cannot invest directly in an index. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. To contact us by mail: Zacks Investment Research To unsubscribe from receiving "Profit from the Pros" e-mail newsletter, click here. | |||||||
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Top Value Stocks
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Insurance Industry Stock Outlook - May 2013
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- AWS 5/21: The Beginning of the End for QE
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
.
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.